U.S. flag An official website of the United States government

U.S. Food and Drug Administration
  1. Home
  2. Drug Databases
  3. Drug Shortages

FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages | Contact Us

Start Over | Back to Previous Screen

Quinapril/Hydrochlorothiazide Tablet
Status: Currently in Shortage
»Date first posted: 01/19/2023
»Therapeutic Categories: Cardiovascular

Expand all

Aurobindo Pharma USA (Reverified 10/15/2025)

Company Contact Information:
866-850-2876

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Quinapril Hydrochloride And Hydrochlorothiazide, Tablet, 12.5 mg; 10 mg (NDC 65862-161-90) Unavailable Discontinuation of the manufacture of the drug Discontinuation of the manufacture of the drug
Quinapril Hydrochloride And Hydrochlorothiazide, Tablet, 12.5 mg; 20 mg (NDC 65862-162-90) Unavailable Discontinuation of the manufacture of the drug Discontinuation of the manufacture of the drug
Quinapril Hydrochloride And Hydrochlorothiazide, Tablet, 25 mg; 20 mg (NDC 65862-163-90) Unavailable Discontinuation of the manufacture of the drug Discontinuation of the manufacture of the drug

Chartwell Molecular Holdings LLC (Reverified 08/19/2025)

Company Contact Information:
845-268-5000 x 510 or Chartwell Customer service at cs@chartwellpharma.com

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Quinapril/Hydrochlorothiazide, Tablet, 25 mg; 20 mg (NDC 62135-669-90) Available
Quinapril/Hydrochlorothiazide, Tablet, 12.5 mg; 20 mg (NDC 62135-668-90) Available
Quinapril/Hydrochlorothiazide, Tablet, 12.5 mg; 10 mg (NDC 62135-667-90) Available
Back to Top